Terazosin hydrochloride anhydrous

α-Methyl-D,L-tyrosine is an antihypertensive TH (tyrosine hydroxylase) inhibitor in pheochromocytoma.

ApplicationDIC ( N,N ′-Diisopropylcarbodiimide) has been used in combination with 1-hydroxy-7-azabenzotriazole (HOAt) for the coupling of amino acid with N -allylglycine to form N -allylpeptide. Valuable reagent offered as a solution in

ApplicationDIC ( N,N ′-Diisopropylcarbodiimide) has been used in combination with 1-hydroxy-7-azabenzotriazole (HOAt) for the coupling of amino acid with N -allylglycine to form N -allylpeptide. Valuable reagent offered as a solution in

Application Diphenylacetic acid can be used as a reagent in the kinetic resolution of racemic 2-hydroxy-&#947-butyrolactones and 1-heteroarylalkanols by asymmetric esterification in the presence of pivalic anhydride and chiral acyl-transfer

Application Diphenylacetic acid can be used as a reagent in the kinetic resolution of racemic 2-hydroxy-&#947-butyrolactones and 1-heteroarylalkanols by asymmetric esterification in the presence of pivalic anhydride and chiral acyl-transfer

Ethyl 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate, HCl.

Ethyl 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate, HCl.

Ethyl 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate, HCl.

May contain varying amounts of anhydride Application Reactant for: Preparation of trisubstituted pyrimidines as phosphatidylinositol 3-kinase inhibitors Preparation of bisphosphonate inhibitors of human farnesyl pyrophosphate synthase

LDN193189 Tetrahydrochloride is a selective BMP type I receptor inhibitor, which efficiently inhibits ALK2 and ALK3 ( IC 50 =5 nM and 30 nM, respectively), with weaker effects on ALK4 , ALK5 and ALK7 (IC 50 ≥500 nM)In VitroLDN193189 inhibits

LDN193189 Tetrahydrochloride is a selective BMP type I receptor inhibitor, which efficiently inhibits ALK2 and ALK3 ( IC 50 =5 nM and 30 nM, respectively), with weaker effects on ALK4 , ALK5 and ALK7 (IC 50 ≥500 nM)In VitroLDN193189 inhibits

LDN193189 Tetrahydrochloride is a selective BMP type I receptor inhibitor, which efficiently inhibits ALK2 and ALK3 ( IC 50 =5 nM and 30 nM, respectively), with weaker effects on ALK4 , ALK5 and ALK7 (IC 50 ≥500 nM)In VitroLDN193189 inhibits